A Phase II, Open-Label Trial Evaluating GV1001 in Advanced Hepatocellular Carcinoma

Update Il y a 4 ans
Reference: NCT00444782

Woman and Man

Extract

The purpose of this study is to investigate the efficacy of GV1001 in locally advanced or metastatic HCC. Also the safety of GV1001 and immunogenicity will be evaluated.


Inclusion criteria

  • Carcinoma, hepatocellular

Links